bioRxiv Science⌕ Search

Biology subjects

Rebillard, A.

Publications and source records attributed to Rebillard, A..

2 recordsLinked to original sources

Voluntary wheel running selectively preserves skeletal muscle during pancreatic cancer cachexia despite persistent systemic alterations

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is frequently associated with cancer cachexia, involving alterations across multiple physiological systems. Whether distinct exercise paradigms similarly influence these compartments remains unclear. We compared voluntary wheel running (VWR) and treadmill running (TR) using an integrative physiological approach in a murine model of pancreatic cancer cachexia. Methods Male C57BL/6J mice bearing UN-KC-6141 pancreatic tumor cells were allocated to inactive control (CaCTL), VWR or TR groups and compared with healthy controls. Tumor progression, body composition, skeletal muscle, adipose tissue, hepatic metabolism, systemic inflammation, energy expenditure and behavior were assessed. Analysis of covariance determined whether tissue-mass differences remained evident after adjustment for tumor burden. Results UN-KC-6141 tumors induced a systemic cachectic phenotype involving skeletal muscle and adipose tissue wasting, hepatic metabolic remodeling, systemic inflammation and behavioral alterations. VWR slowed tumor growth, reduced final tumor mass, improved the body-weight trajectory and preserved lean and skeletal muscle mass, whereas TR did not reproduce these adaptations. Greater gastrocnemius mass with VWR remained evident after adjustment for tumor mass, indicating that reduced tumor burden alone was insufficient to account for muscle preservation. In contrast, adipose tissue wasting, hepatic metabolic remodeling and systemic inflammation remained largely unaffected. TR was also associated with a less favorable body-weight trajectory and greater fat mass loss than in inactive tumor-bearing mice. Exploratory metabolic phenotyping revealed distinct feeding, sleep and resting energy expenditure patterns between the two exercise paradigms. Conclusions VWR selectively preserved skeletal muscle within a persistently altered systemic environment, whereas the TR protocol used here did not reproduce these adaptations. These findings reveal tissue-specific exercise responsiveness during pancreatic cancer cachexia and highlight exercise paradigm characteristics as determinants of tumor-host adaptation.

physiology↗

Distinct iron metabolism regulation during cachexia progression in murine models of intestinal and pancreatic cancer

Background. Cancer cachexia is a multifactorial syndrome characterized by substantial metabolic disturbances including systemic inflammation, and muscle atrophy, which may affect the regulation of iron metabolism in patients. This study aimed to characterize this regulation in two murine models of colorectal and pancreatic cancer, both associated with a high prevalence of cachexia. Methods. Histological, biochemical and molecular analyses were performed in serum, skeletal muscle, liver, spleen and tumor from UN-KC-6141 pancreatic tumor bearing mice and from ApcMin/+ mice (colorectal cancer model), both models exhibiting variable cachexia severity. Results. Both models induce cachexia, but diverge markedly in their regulation of iron metabolism. UNKC mice display reduced plasma iron availability (-9.6% transferrin saturation, p<0.001) without concomitant anemia, while hepatic hepcidin synthesis is upregulated (+100.6%, p<0.001) by inflammation, promoting ferroportin (FPN) downregulation (-42.4%, p<0.001) and iron sequestration in the spleen (+134% total iron content, p<0.001). In the atrophied gastrocnemius, iron concentration is preserved through increased ferritin (+86.6%, p=0.010) and hemoproteins (i.e., myoglobin, CYSC, COXIV) expression. Conversely, ApcMin/+ mice exhibit anemia together with hepatic and splenic iron depletion (-48.4%, p<0.001 and -84.9%, p<0.001, respectively). Hepcidin synthesis is downregulated (-99.9%, p<0.001) despite persistent inflammation, indicating that hypoxia and/or iron-deficiency signals probably predominate over the inflammatory pathway. FPN is markedly decreased (-94.2%, p<0.001) in the iron-depleted spleen despite low hepcidin. In the atrophied quadriceps of ApcMin/+ mice, iron deficiency is associated with decreased FPN and ferritin (-87.9%, p<0.001, and -38.4%, p=0.016, respectively), and increased TfR1 expression (+305%, p=0.107). Finally, tumor iron import may play a significant role in cachexia progression, as suggested by the association between tumor weight, tumor TfR1 protein levels and body weight loss in UNKC mice. Conclusion. These findings reveal cancer type-specific signatures of iron regulation in cachexia, which appear to be more driven by cancer type specific features than by cachexia severity itself, with skeletal muscle iron metabolism impaired mainly when cachexia is associated with anemia. This suggests that the clinical management of iron metabolism in cachectic patients should be guided by the underlying cancer type.

physiology↗